OncoZenge registers 772,797 shares in directed issue after SEK 5 million payment from Sichuan Yangtian

Reuters2026/08/21 10:54

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

OncoZenge registered 772,797 new shares from a directed share issue to Sichuan Yangtian Bio-Pharmaceutical following SEK 5 million payment.
Subscription price set at SEK 6.47 per share; placement targets total proceeds of about SEK 15.1 million.
Share count rose to 14,820,865 from 14,048,068; dilution from the registered tranche estimated at about 5.2%.
Remaining 1,562,026 shares stay unregistered pending about SEK 10.1 million; payment deadline extended to Aug. 28, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncozenge AB published the original content used to generate this news brief on August 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

OncoZenge registers 772,797 shares in directed issue after SEK 5 million payment from Sichuan Yangtian

You may also like

Crypto prices